https://www.ncbi.nlm.nih.gov/pubmed/26256952
Harlev A, Gupta S, Agarwal A. Targeting oxidative stress to
treat endometriosis. Expert Opin Ther Targets
2015;19(11):1447-64.
https://www.sciencedirect.com/science/article/pii/B9780123969880000143
https://pubmed.ncbi.nlm.nih.gov/20028959/
Bendz LM, Scates AC. Melatonin treatment for insomnia in
pediatric patients with attention-deficit/hyperactivity disorder. Ann
Pharmacother 2010;44(1):185-91.
https://pubmed.ncbi.nlm.nih.gov/22952551/
Mohammadi MR, Mostafavi SA, Keshavarz SA, Eshraghian MR,
Hosseinzadeh P, Hosseinzadeh-Attar MJ, Kooshesh SM, Chamari M,
Akhondzadeh S. Melatonin effects in methylphenidate treated children
with attention deficit hyperactivity disorder: a randomized double
blind clinical trial. Iran J Psychiatry 2012;7(2):87-92.
https://pubmed.ncbi.nlm.nih.gov/35029046/
Jarrott B, Head R, Pringle KG, Lumbers ER, Martin JH. "LONG
COVID"-A hypothesis for understanding the biological basis and
pharmacological treatment strategy. Pharmacol Res Perspect
2022;10(1):e00911.
https://pubmed.ncbi.nlm.nih.gov/32347747/
Shneider A, Kudriavtsev A, Vakhrusheva A. Can melatonin reduce
the severity of COVID-19 pandemic? Int Rev Immunol
2020;39(4):153-162.
https://pubmed.ncbi.nlm.nih.gov/16948779/
Pereira Rde S. Regression of gastroesophageal reflux disease
symptoms using dietary supplementation with melatonin, vitamins and
aminoacids: comparison with omeprazole. J Pineal Res
2006;41(3):195-200.
https://pubmed.ncbi.nlm.nih.gov/20028959/
Bendz LM, Scates AC. Melatonin treatment for insomnia in
pediatric patients with attention-deficit/hyperactivity disorder. Ann
Pharmacother 2010;44(1):185-91.